KeyCorp (KEY) reported better-than-expected revenue and earnings for the fourth quarter of 2018 but the stock dipped 0.9% during premarket hours on Thursday.
Total revenues grew 2.8% to $1.65 billion compared to the same period last year. Net income attributable to common shareholders improved to $461 million or $0.45 per share from $182 million or $0.17 per share in the prior-year period. Adjusted EPS was $0.48.
Taxable-equivalent net interest income grew 5.9% to $1 billion and net interest margin rose to 3.16% from 3.09% in the year-ago quarter, reflecting benefits from higher interest rates and higher earning asset balances. Noninterest income dropped 1.7% to $645 million. Noninterest expense dropped 7.8% to $1 billion during the quarter.
Average loans grew 3.8% to $89.3 billion from last year while average deposits rose 4% to $108 billion. The growth in average loans reflected broad-based growth in commercial and industrial loans and the growth in average deposits reflected growth in higher-yielding deposit products along with strength in the retail banking franchise and growth from commercial relationships.
Also see: KeyCorp Q4 2018 Earnings Transcript
Provision for credit losses increased to $59 million from $49 million in the prior-year period. Net loan charge-offs totaled $60 million versus $52 million last year. At quarter-end, the company’s tangible common equity ratio was 8.30%.
Revenue from continuing operations increased 6.3% for the Key Community Bank segment while for the Key Corporate Bank, it declined 4%. Profits for the Key Community Bank segment increased 71.7% helped by momentum in core businesses, expense discipline and a lower tax rate. In the Key Corporate Bank segment, profits dropped 3.6%.
Get access to timely and accurate verbatim transcripts that are published within hours of the event.
Most Popular
United Parcel Service (UPS) seems on track to regain lost strength
Cargo giant United Parcel Service, Inc. (NYSE: UPS) ended fiscal 2023 on a weak note, reporting lower revenues and profit for the fourth quarter. The company experienced a slowdown post-pandemic
IPO Alert: What to look for when Boundless Bio goes public
Boundless Bio is preparing to debut on the Nasdaq stock market this week, and become the latest addition to the list of biotech firms that have launched IPOs this year.
Nike (NKE) bets on innovation and partnerships to return to high growth
Sneaker giant Nike, Inc. (NYSE: NKE) has been going through a rough patch for some time, with sales coming under pressure from weak demand and rising competition. Post-pandemic, the company